Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

123 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Active, Not Recruiting

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

NCT06253520

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +41 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

NCT05067140

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: Clinical Trial Site Duarte, California, United States

Clinical Trial Site Fresno, California, United States

Clinical Trial Site La Jolla, California, United States

Clinical Trial Site Orange, California, United States

View all 23 locations

View Trial Details

Active, Not Recruiting

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

NCT04597411

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: St. Vincent's Hospital Research Office-Translational Research Center Darlinghurst, Australia

Steve Biko Hospital-Department of Nuclear Medicine Pretoria, South Africa

View Trial Details

Active, Not Recruiting

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

NCT05509751

Conditions: Adherence Interventions, Behavior, Breast Cancer, +33 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

Sunybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

NCT05902520

Conditions: Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +38 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Active, Not Recruiting

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

NCT03794635

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, +20 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

NCT06229366

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations: Juravinski Hamilton, Canada

Jewish General Hospital Montreal, Canada

McGill University Montreal, Canada

Centre Hospitalier Universite de QUEBEC Québec, Canada

View Trial Details

Active, Not Recruiting

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

NCT02735252

Conditions: Advanced Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Female Urogenital Diseases, +17 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Active, Not Recruiting

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

NCT05629065

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +17 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

NCT06384417

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +47 more
Locations: Penn State Cancer Institute Hershey, Pennsylvania, United States

View Trial Details

Urogenital Neoplasms

Urogenital Neoplasms trial results

Related conditions